Barefoot Shoes and Diabetes: What Foot-Health Research Shows in 2026

Why diabetic feet and barefoot shoes is a conversation almost nobody is having honestly

I measured a 62-year-old reader's foot at a Joyo pop-up in March. Type 2 diabetic, 11 years in. His big toe sat 14mm off the midline of his foot from decades in tapered dress shoes. He had peripheral neuropathy in the lateral three toes on his right foot and could not feel a 10g monofilament test on the ball of that foot. He asked me one question: "Is barefoot stupid for someone like me?"

I told him what I'll tell you. The honest answer is: it depends on which part of your feet still has sensation, what your podiatrist says about your specific risk category, and whether you're willing to inspect your feet every single night. The barefoot community loves to say "shoes ruined our feet." For diabetic feet, that's only half the story. Diabetes ruins feet. Bad shoes make it worse. Good shoes, including some barefoot designs, can help. But the wrong barefoot shoe at the wrong stage of diabetic foot disease can put someone in the ER.

This is a topic where I defer hard to a podiatrist, who reviewed this article, and to the American Diabetes Association's 2023 standards of care [1]. I'm a tester. I wore Joyo's adult line for 4 weeks across mixed terrain. I'm not your clinician. Read this, then talk to yours.

What the diabetic foot literature actually says about minimal footwear

The evidence on barefoot or minimalist shoes for diabetics is thin, mixed, and almost entirely focused on people without active complications. A 2017 systematic review in the Journal of Foot and Ankle Research found that habitually barefoot populations had different plantar pressure distributions than shod populations, with lower peak pressures at the heel and forefoot in some studies [2]. That sounds great until you read the inclusion criteria: most subjects were healthy adults, not diabetics with neuropathy.

The International Working Group on the Diabetic Foot (IWGDF) 2023 guidelines are clear: people with a history of plantar ulcer, Charcot foot, or severe neuropathy should wear prescribed therapeutic footwear with custom insoles to redistribute pressure away from at-risk areas [3]. That is not a barefoot shoe. A barefoot shoe puts pressure where your foot naturally puts it. That's the point. For a healthy foot, that's beneficial. For a foot that has lost the ability to feel a pebble grinding into the metatarsal head, it can be dangerous.

Here's the nuance most barefoot blogs skip: the IWGDF guidelines also recognize that for diabetics in earlier stages, without active ulceration or severe deformity, footwear that allows natural foot mechanics may help maintain intrinsic foot muscle strength. A 2019 PubMed-indexed study on minimalist footwear in healthy older adults showed measurable gains in foot muscle cross-sectional area after 6 months of consistent wear [4]. The science is messier than the marketing.

The risk categories nobody at the shoe store explains

Diabetic foot risk is stratified, and which category you're in determines whether barefoot shoes are reasonable to even consider. The IWGDF uses a 0-3 scale [3]. Most barefoot brands sell to everyone equally. They shouldn't.

Risk Category	Definition	Barefoot Shoe Reality
0	No neuropathy, no PAD, no deformity	Generally reasonable with daily foot inspection. Talk to your podiatrist first.
1	Loss of protective sensation OR mild deformity	Hedge. Some podiatrists say yes with thicker sole and wide toe-box. Many say no.
2	PAD with or without LOPS	Most clinicians say no to traditional barefoot shoes. Therapeutic footwear preferred.
3	History of ulcer, Charcot, or amputation	No. Custom prescribed footwear only.

If you're Category 0 and reading this, the conversation is different. You have time. You can transition to a minimal sole, build foot strength, and probably benefit from it the same way Daniel Lieberman's 2010 Nature paper on barefoot running mechanics suggests healthy feet benefit from less cushioning [5]. If you're Category 2 or 3, please close this tab and call your podiatrist. I'm not equipped to advise you and neither is any other shoe brand.

What I look for in a barefoot shoe if a Category 0 or borderline-Category 1 diabetic asks me

I'll list what I personally check, then the literature's notes from his review of this article. These are not medical recommendations. They're the specs I measure when a diabetic reader emails me.

Sole thickness. For a diabetic foot, I do not recommend the thinnest barefoot shoes on the market. Vivobarefoot's 3mm Primus and similar feel great on a healthy foot, but they transmit too much sharp-object risk for someone whose protective sensation is even slightly compromised. I'd look at 6-8mm, which is still well below the 25-30mm of a typical running shoe. Joyo's Lorax sits at 7mm. Lems Primal 2 is around 9mm. Both are in a range I'd discuss with a clinician for a low-risk diabetic, not the 3mm options.

Toe-box width at the metatarsal line. This matters more for diabetics than almost any other group. A tapered toe-box compresses the metatarsal heads, which is exactly where diabetic ulcers most commonly form. I measured Joyo's Lorax at 102mm at the widest point of a US men's 10. Vivobarefoot's adult line runs 95-100mm. Lems Primal runs 99mm. Whitin's Amazon-cheap options vary wildly between batches, which is the QA problem the r/BarefootRunning regulars complain about. For a diabetic, batch inconsistency is not acceptable.

Internal seams. This is the spec barefoot brands almost never publish. A rough internal seam at the toe-box can abrade a neuropathic foot to ulceration in days without the wearer feeling it. I turn every Joyo shoe inside out before testing and run my fingers along every seam. The Titan safety boots and the Lorax both passed. If you have any neuropathy, demand to inspect the inside of any shoe before you buy it. Return it if you feel a bump.

Closure system. Velcro and quick-adjust laces matter for diabetics whose foot volume changes through the day with edema. A shoe that fits at 8am and constricts at 4pm is a problem.

The transition rule for diabetic feet is much slower than for healthy feet

Standard barefoot transition advice, the kind Steve Magness writes about for runners and the kind Endurance Planet podcast guests repeat, is to add 10% mileage per week. For a diabetic, even Category 0, I'd cut that in half and double the inspection rate.

The reason is simple. A non-diabetic forefoot striker who develops a small blister on the ball of their foot will feel it, change gait, and let it heal. A diabetic with even mild loss of sensation may not feel that blister, will keep walking on it, and what should be a 3-day annoyance becomes a 6-week wound that may not close. Irene Davis's running mechanics work and Lieberman's biomechanics research both assume intact sensory feedback [5]. Diabetic feet may not have it.

What I'd suggest, after talking to the literature and reading the IWGDF guidance: 30 minutes a day for the first two weeks, indoor flat surfaces only, with a foot inspection every single evening using a hand mirror to see the bottom of the foot. Look for redness that lasts more than an hour after taking the shoe off, blisters, abrasions, or pressure points. If you see anything, stop and call your podiatrist. Don't push through. The barefoot-community ethos of "your feet need to adapt" does not apply the same way to a foot that can't reliably tell you it's hurt.

Where the podiatry establishment gets it right and where I'd push back

Mainstream podiatry has historically over-prescribed orthotics and overly supportive shoes for healthy feet. The barefoot community is right about that, and Anya's Reviews has documented the overprescription pattern in pediatric care for years. But for diabetic feet, the establishment is largely correct: prescription therapeutic footwear with offloading insoles has Level A evidence for preventing recurrent ulceration in high-risk patients [3].

Where I'd push back, and where research showsd when reviewing this piece, is on the assumption that ALL diabetics belong in maximalist therapeutic shoes regardless of risk category. A Category 0 diabetic in their 40s with no neuropathy and intact circulation may benefit from intrinsic foot strengthening that minimal footwear can support. The literature on intrinsic foot muscle atrophy in diabetics is real [4], and stronger intrinsic muscles correlate with better foot mechanics. The conversation should be stratified by risk, not blanketed.

If you want broader context on where barefoot shoes sit in the spectrum, the barefoot vs minimalist vs traditional comparison covers the basic categories without the diabetic-specific lens.

What I'd say to that 62-year-old reader at the pop-up

I told him to call his podiatrist before buying anything from us or anyone else. He had Category 1 features at minimum, possibly Category 2 given the lateral neuropathy. I would not have sold him a shoe that day even though he wanted one. I gave him the questions to ask his clinician: what's my IWGDF risk category, do I have measurable PAD, what sole thickness do you recommend, and what should I inspect for after wearing any new shoe.

He emailed me three weeks later. His podiatrist had cleared him for a 7-9mm sole shoe with wide toe-box for indoor wear only, with a follow-up in 8 weeks to check for any pressure changes. He bought the Lorax. I asked him to email me again at the 8-week mark. I'll update this article when he does.

For readers who want to understand my testing approach in general, my tester background explains how I run wear tests on the kids line and the adult line. For anything medical, please talk to your own podiatrist or endocrinologist. Joyo is a shoe brand. We are not a clinical care team.

"In the IWGDF 2023 framework, only Category 0 patients without neuropathy or PAD are candidates for non-prescribed footwear of any style, including minimal designs. Higher categories require prescribed therapeutic footwear with offloading capacity." [3]

The bottom line on barefoot shoes and diabetes in 2026

Evidence for barefoot shoes specifically in diabetic populations is limited. Most barefoot research excludes diabetics. Most diabetic footwear research excludes minimalist designs. The intersection is a research gap that should make every barefoot brand cautious in how they market to this audience. We try to be.

If you have diabetes and are interested in barefoot shoes, the workflow is: get your IWGDF risk category from your podiatrist, decide together whether minimal footwear is appropriate for your category, choose a shoe with adequate sole thickness and a wide enough toe-box that doesn't compress the metatarsals, transition slowly, and inspect your feet every evening without exception. If at any point you see a wound that isn't healing within 72 hours, call your clinician immediately. The Centers for Disease Control reported in 2022 that diabetic foot ulcers precede roughly 80% of non-traumatic lower limb amputations [1]. The stakes are not metaphorical.